(Press-News.org) Colorectal cancer remains a leading cause of cancer death, with incidence rising among older adults. One of the most pressing clinical questions has been whether elderly patients should receive oxaliplatin, a standard component of adjuvant chemotherapy that is known to cause serious side effects.
To address this, Dr. Jun Woo Bong from Korea University Guro Hospital, with Dr. Hwamin Lee, and Dr. Seogsong Jeong from Korea University College of Medicine, conducted a large-scale population study, which was made available online on August 6, 2025, in JAMA Network Open.
The team examined health records from more than 8,500 patients with stage II or III colorectal cancer who underwent surgery followed by chemotherapy between 2014 and 2016. Patients were divided into two groups: those treated with oxaliplatin-based combinations, and those given standard chemotherapy alone. Using advanced statistical methods, the researchers systematically tested whether an age threshold existed at which oxaliplatin stopped providing survival benefits.
The results were decisive. In stage III patients aged 70 or younger, oxaliplatin reduced the risk of death by 41%, boosting five-year survival from 78% to nearly 85%. But in those older than 70, oxaliplatin did not improve survival and was linked to higher rates of treatment discontinuation. In fact, almost 40% of older patients receiving oxaliplatin stopped chemotherapy early, often due to toxicity. For stage II patients of any age, oxaliplatin showed no added survival benefit.
“The most important point is that oxaliplatin improves survival only in patients with stage III colorectal cancer who are aged 70 years or younger. Beyond 70, the benefit disappears, and oxaliplatin is associated with higher discontinuation rates due to toxicity,” said Dr. Bong.
These findings have immediate real-world applications.
“Oncologists can use this age threshold to make more precise, evidence-based choices about whether to add oxaliplatin, avoiding unnecessary toxicity in patients unlikely to benefit,” said Dr. Jeong.
The broader significance extends to healthcare policy. Avoiding ineffective chemotherapy in older patients may help reduce costs, complications, and hospitalizations. Health systems could redirect resources to therapies and supportive care that make a greater difference in survival and quality of life. The research also sets the stage for longer-term changes in global cancer care.
“Clinical practice guidelines may adopt age 70 as a critical factor in recommending oxaliplatin, laying the foundation for precision oncology and future research focused on safer, more effective treatments for older patients,” said Dr. Lee.
The authors note some limitations, including the retrospective design and lack of molecular marker data. Even so, the sheer size of the national dataset lends strong weight to the findings, which are likely to influence both clinical guidelines and everyday oncology practice. As cancer treatment increasingly moves toward personalization, this study underscores the importance of tailoring care not only to tumor stage but also to patient age and resilience. For younger stage III patients, oxaliplatin remains an important tool. For those beyond 70, it may be time to reconsider and focus on therapies that preserve both survival and quality of life.
***
Reference
DOI: http://doi.org/10.1001/jamanetworkopen.2025.25660
About Korea University College of Medicine
Korea University College of Medicine is the medical school of Korea University. It is located in Seoul, South Korea. As one of the oldest medical schools in South Korea, it has been historically regarded as one of the country's top medical schools. The school was founded as Chosun Women's Medical Training Institute in 1928 by Rosetta Sherwood Hall. The institute was subsequently renamed several times and ultimately merged with Korea University to become Korea University College of Medicine. So far, the school has produced over 7,000 graduates, most of whom are working as prominent physicians and public health advocates worldwide.
Website: https://medicine.korea.ac.kr/en/index.do
About the author
Prof. Jun Woo Bong is a colorectal surgeon and Associate Professor at Korea University Guro Hospital and Korea University College of Medicine. His work focuses on surgical outcomes, chemotherapy optimization, and population-based analyses of colorectal cancer. He has led multiple national database studies exploring treatment effectiveness, patient safety, and age-specific strategies in cancer care. Prof. Bong is also committed to advancing precision oncology by integrating clinical evidence and genetic mechanisms to overcome resistance to chemotherapy to improve outcomes and quality of life for patients with colorectal disease.
END
COLUMBUS, Ohio – Research led by The Ohio State University Wexner Medical Center and College of Medicine explores the ways brain cells communicate, revealing fresh insight into the progression of Alzheimer’s disease.
A multidisciplinary team used advanced imaging and computational modeling to analyze the “crosstalk” between neurons and their supporting glial cells in the human brain. This approach highlights the brain’s interconnected cellular network.
“By mapping these cell interactions at the molecular level, we identified key pathways ...
Scientists regularly uncork fresh insights into beer and wine — even though they were invented thousands of years ago. Four recent discoveries go beyond buzz and bouquet, diving into the haziness and gluten content of beer as well as the astringent taste and potential health impacts of wine. Sip back and learn more about research published in ACS’ Journal of Agricultural and Food Chemistry. Reporters can request free access to these papers by emailing newsroom@acs.org.
Yeast extracts add haze to lager beer. Hazy beer styles are becoming more popular, ...
Evanston, Ill. – September 10, 2025 – The Massage Therapy Foundation (MTF) announces the award of a research grant to Children’s Hospital of Philadelphia (CHOP). The grant will support a three-year study entitled Myofascial Release Therapy in Irritable Bowel Syndrome led by Primary Investigators Maria Mascarenhas, MBBS and Alain J. Benitez, MD, MSTR.
The study aims to evaluate the impact of abdominal myofascial release (MFR)—a gentle, manual therapy—on symptom relief, quality of life, and bowel function in adolescents with constipation-predominant irritable bowel syndrome (IBS-C). This randomized controlled study pairs MFR with ...
The growing global demand for clean energy and rising concerns over climate change have intensified the search for sustainable alternatives. Hydrogen emerges as a promising solution due to its high energy density and zero-carbon emissions. Among production methods, alkaline water electrolysis is efficient and environmentally friendly; however, its dependence on freshwater limits large-scale implementation. Seawater electrolysis offers a practical alternative by tapping Earth’s abundant water resources but contains high chloride concentrations that accelerate catalyst corrosion and reduce efficiency, posing a significant ...
Richmond Hill, Canada, 18 September 2025 – On August 31 at midnight, a magnitude 6.0 earthquake struck Afghanistan’s eastern Kunar Province near the Pakistan border. Despite being moderate in magnitude, the earthquake caused extensive destruction and claimed more than 3,500 lives, including many women and children. Now, the United Nations University (UNU) scientists attribute this significant death toll to Afghanistan's decades of conflict and instability, and the nation's increasing diplomatic isolation following the Taliban takeover in 2021.
A new damage assessment of the August 31 earthquake by the United ...
An international group of four leading researchers and scientists have been shortlisted for the prestigious $75,000 Panmure House Prize.
This year’s competition attracted entries from across North America, Europe, and beyond, reflecting the global reach of the award.
Now in its fifth year, the Prize is named after Panmure House, the former Edinburgh residence of 18th-century Scottish economist and philosopher Adam Smith. It is regarded as one of the largest awards in financial research and is dedicated to advancing understanding of long-term ...
Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from University of California San Diego and Yale University researchers highlights an innovative alternative approach that may be safer.
CRISPR — short for clustered regularly interspaced short palindromic repeats — is a method of genetic editing that uses RNA and bacterial proteins to edit DNA. It was adapted from a method used by bacteria as an immune defense against the DNA of viruses.
When the method is used by scientists to edit human DNA, however, there ...
Astronomers have used observatories around the world, including the European Southern Observatory's Very Large Telescope (ESO’s VLT), to study the asteroid 1998 KY26, revealing it to be almost three times smaller and spinning much faster than previously thought. The asteroid is the 2031 target for Japan’s Hayabusa2 extended mission. The new observations offer key information for the mission’s operations at the asteroid, just six years out from the spacecraft’s encounter with 1998 KY26.
“We found that the reality of the object is completely different from what it was previously described as,” says ...
You have 20 minutes of spare time, but the new episode of your favorite podcast is a few minutes longer. No problem; you can increase the listening speed and fit in those extra minutes.
Phew.
What happens when you listen to speech at a different speed? Neuroscientists thought that your brain may turn up its processing speed as well. But it turns out that at least the auditory part of the brain keeps “listening” or clocking in at a fixed time. That is the key finding of new research out today in Nature Neuroscience. The research was led by Sam Norman-Haignere, PhD, ...
A team led by Christian Baumgartner of the Institute of Health Care Engineering at Graz University of Technology (TU Graz) has developed a highly detailed digital twin of the A549 lung cancer cell line. The twin builds on bioelectric processes and calcium dynamics in the cell interior in innovative new ways. Calcium is a vital component in the survival of biological cells. However, if the concentration of calcium within a cell is too high, this can cause cell death – which is what makes the element such an interesting factor in cancer treatment. Created under the DigLungCancer project, the cell model builds on an earlier model from 2021 – ...
